SWKH
Undervalued by 158% based on the discounted cash flow analysis.
Market cap | $220.71 Million |
---|---|
Enterprise Value | $259.34 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $1.25 |
Beta | 0.27 |
Outstanding Shares | 12,476,749 |
Avg 30 Day Volume | 6,560 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 13.89 |
---|---|
PEG | 3278.68 |
Price to Sales | 5.9 |
Price to Book Ratio | 0.8 |
Enterprise Value to Revenue | 6.87 |
Enterprise Value to EBIT | 13.94 |
Enterprise Value to Net Income | 16 |
Total Debt to Enterprise | 0.17 |
Debt to Equity | 0.15 |
No data
No data
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...